Search results

Selected filters:

Analysis
Law & Policy

Article type

Topic

Sector

Regions

Year

1,364 results found for your search

Sort options
03 December 2019

China rolls out blacklist for patent offenders

New initiative could strengthen rights holders’ tools for compelling enforcement of Chinese court decisions – a continuing challenge

29 November 2019

China’s ByteDance launches first smartphone amidst US government scrutiny

Beijing-based company is expanding from software to hardware, but video app TikTok’s runaway stateside success has put a target on its back

27 November 2019

FDA takes rare step of revoking orphan drug status

The decision means that Indivior’s Sublocade is no longer eligible for lucrative exclusivity, but leaves concerns about evergreening unaddressed

27 November 2019

China gets a new high-level blueprint for IP reform

The policy document contains plenty of positives, but it is not the trade breakthrough some media outlets are suggesting

21 November 2019

US Presidential hopefuls set their sights on pharma patents

With several leading Democratic candidates threatening to circumvent pharma IP, next year’s election could prove pivotal for right owners

19 November 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

14 November 2019

Legal landscape more rational now but will shift back, says Facebook IP supremo

Get your deals done now before the market begins to rebalance in favour of patent owners, Allen Lo advises licensees while speaking on panel at the annual IP Dealmakers conference

13 November 2019

EPO agreement to boost Chinese companies' Europe push

Foreign companies with R&D in China may also benefit from deal opening up PCT search options

12 November 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016

08 November 2019

Micron lawyers say Hong Kong is too risky for trade secret exchange

But a US federal judge ruled last month that UMC and Fujian Jinhua can review Micron’s evidence against them in the Special Administrative Region

07 November 2019

The USPTO's consultation on patent issues relating to AI seeks answers on key questions

Artificial intelligence has the potential to change the entire nature of the invention process and, therefore, the criteria under which patents are awarded

06 November 2019

We’re keeping a very close eye on <em>Arthrex, </em>says Iancu at <em>IAM</em> event in Washington DC

Major Federal Circuit decision on PTAB judges leaves stakeholder community looking for answers and, possibly, to a statutory solution 

06 November 2019

Chinese patents surviving validity challenges in greater numbers

Invention patents had a coin flip chance of full invalidation by CNIPA over the past decade, but the past three years show a higher survival rate

05 November 2019

Top tips for patenting personalised medicine 

As medical treatments become increasingly bespoke, we reveal some best practices to help inventors secure the highest quality patents possible.

05 November 2019

Monsanto prevails in key $7.7 billion Brazilian licensing lawsuit

In a big win for patent owners, the first-of-its-kind ruling upholds biotech innovators’ rights to collect royalties on saved GM seeds